Optiver Holding
AXSM icon

Optiver Holding’s Axsome Therapeutics AXSM Stock Holding History

Optiver Holding’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$11.7K Sell
69
-43
-38% -$7.43K ﹤0.01% 1193
2025
Q4 		$20.5K Sell
112
-176
-61% -$24.6K ﹤0.01% 1023
2025
Q3 		$35K Buy
288
+130
+82% +$14.6K ﹤0.01% 849
2025
Q2 		$16.5K Buy
158
+98
+163% +$10.4K ﹤0.01% 884
2025
Q1 		$7K Buy
+60
New +$6.84K ﹤0.01% 1003

Other funds holding AXSM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Optiver Holding's AXSM Position: Q1 2026 in Review

Optiver Holding reduced its Axsome Therapeutics (AXSM) stake by 38% in Q1 2026, selling an estimated $7.43K and leaving 69 shares worth $11.7K. The position accounts for ﹤0.01% of the portfolio, ranked #1193.

Optiver Holding first reported a position in AXSM in Q1 2025 and has held it in 5 quarters since. The position peaked at $35K in Q3 2025. 409 funds tracked by Wall St. Rank hold AXSM as of Q1 2026.

  • Optiver Holding held 69 shares of Axsome Therapeutics worth $11.7K as of Q1 2026.
  • Optiver Holding sold 43 Axsome Therapeutics shares in Q1 2026, an estimated $7.43K.
  • Axsome Therapeutics made up ﹤0.01% of Optiver Holding's portfolio in Q1 2026, its #1193 holding.
  • Optiver Holding first reported a position in Axsome Therapeutics in Q1 2025 and has held it in 5 quarters since.
  • Optiver Holding's Axsome Therapeutics position peaked at $35K in Q3 2025.
  • 409 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q1 2026.

Based on Optiver Holding's 13F filing for Q1 2026, filed 15 May 2026.